Recombinant Human PTPRA Protein，His

PTPRA (Protein Tyrosine Phosphatase Receptor Type A) is a member of the protein tyrosine phosphatase family, which plays a crucial role in regulating various cellular processes, including cell growth, differentiation, and signaling pathways. Dysregulation of PTPRA has been implicated in various diseases, particularly cancer, where it may contribute to tumor progression and metastasis. The study of PTPRA recombinant proteins is essential for understanding its structure-function relationships and elucidating the molecular mechanisms behind its activity. Researchers have focused on producing recombinant PTPRA to facilitate in vitro studies that assess its enzymatic functions, interactions with substrates, and potential as a therapeutic target. By generating PTPRA in a controlled environment, scientists can investigate the effects of specific mutations, post-translational modifications, and other factors that influence its activity. Furthermore, understanding PTPRA's role in tumor biology could lead to the development of novel biomarkers and targeted therapies, making it a significant focus of ongoing cancer research. Through the expression and purification of PTPRA recombinant proteins, researchers aim to advance our knowledge of this phosphatase's functions and its implications in health and disease, thereby opening new avenues for therapeutic interventions.